FDA semi-annual agenda
This article was originally published in The Rose Sheet
Executive Summary
A notice of proposed rulemaking for topical antimicrobial consumer products and healthcare antiseptics is slated for release in March, according to FDA's semi-annual agenda, published in Oct. 31 Federal Register. Agency is working to finalize a tentative final monograph for topical antimicrobials published in the June 1994 Federal Register. In October, the Nonprescription Drugs Advisory Committee met to address questions regarding the safety and efficacy of consumer antimicrobials (1"The Rose Sheet" Oct. 24, 2005, p. 9). Additional items on the semi-annual agenda include an amendment to the NPRM for OTC dandruff, seborrheic dermatitis and psoriasis products in December and technical amendments to the final action for skin protectant products marketed as lip protectants in December. The agency expects to release an NPRM for skin bleaching products in March and final action for plaque gingivitis products is slated for October of next year...
You may also be interested in...
FDA semi-annual agenda
Notice of proposed rulemaking for OTC UVA/UVB sunscreens is expected to be released this month, according to FDA's semi-annual agenda, published in an April 24 Federal Register 1notice. Agency anticipated a December 2005 release date for the rule in its last semi-annual agenda (2"The Rose Sheet" Nov. 7, 2005, In Brief). FDA partially stayed the OTC final sunscreen monograph in 2002 to develop UVA/UVB guidelines. Additional items on the semi-annual agenda include releasing NPRM for skin bleaching products this month and NPRM for OTC topical antimicrobial drug products in December. Final action on OTC dandruff, seborrheic dermatitis and psoriasis products is slated for August, and FDA aims to issue technical amendments to the final action on skin protectant products in June...
Non-Alcohol Antiseptic Hand Products Should Prove Efficacy – NDAC
Marketers of non-alcohol-based consumer antiseptic products should be required to prove their products provide clinical benefit prior to sale, an FDA advisory panel unanimously agreed Oct. 20
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.